· Журналы · Книги · О проекте ·Электронные версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru ИНТЕРНЕТ-МАГАЗИН    Лечебное дело 2014 / N 1 Синдром обструктивного апноэ сна: современное состояние проблемы (библиография) Д.С. Шамшева Список литературы 1. Богданов А.Р., Залетова Т.С., Богданов Р.Р. Показатели метаболометрии у больных с заболеваниями сердечно-сосудистой системы и ожирением // Доктор.Ру. № 10. 2012. С. 17–23. 2. Бузунов Р.В., Легейда И.В // Царева Е.В. Храп и синдром обструктивного апноэ сна у взрослых и детей. Практическое руководство для врачей. М., 2012. 3. Голубева А.А., Сильвестрова Г.А. Лечение нарушений сердечного ритма и проводимости при синдроме обструктивного апноэ сна // Лечебное дело. 2010. № 3. С. 91–96. 4. Курлыкина Н.В. Брадиаритмии во время сна: связь с синдромом обструктивного апноэ и влияние терапии постоянным положительным давлением. Автореф. М., 2009. 5. Литвин А.Ю. Особенности диагностики, поражения органов-мишеней и лечения больных с артериальной гипертонией и синдромом обструктивного апноэ во время сна // Дис… Литвина А.Ю. М., 2009. 6. Мартинчик А.Н., Маев И.В., Янушевич О.О. Общая нутрициология: Учебное пособие для вузов. М., 2005. 7. Матова Е.А. Синдром апноэ во сне // Здоровая Украина. 2007. № 2. С. 28–29. 8. Пальман А.Д. Синдром обструктивного апноэ во сне в терапевтической практике. Пособие для врачей / Под ред. Синопальникова А.И. М., 2007. 9. Шевченко О.П., Мишнев О.Д., Шевченко А.О. и др. Ишемическая болезнь сердца. М., 2005. 10. Altekin R.E., Yanıkoğlu A., Karakaş M.S. et al. Evaluation of subclinical left ventricular systolic dysfunction in patients with obstructive sleep apnea by automated function imaging method; an observational study // AnadoluKardiyolDerg. 2012. V. 12. P. 320–330. 11. Arnaud C., Dematteis M., Pepin J.L. et al. Obstructive sleep apnea, immuno-inflammation, and atherosclerosis // Semin Immunopathol. 2009. V. 31. P. 113–125. 12. Aronsohn R.S., Whitmore H., Van Cauter E. et al. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes // Am J RespirCrit Care Med. 2010. V. 181. P. 507–513. 13. Aslan M., Horoz M., Sabuncu T. et al. Serum paraoxonase enzyme activity and oxidative stress in obese subjects // Pol. Arch. Med. Wewn. 2011. V. 121. P. 181–186. 14. Atkeson A., Yeh S.Y., Malhotra A., Jelic S. Endothelial function in obstructive sleep apnea // ProgCardiovascDis. 2009. V. 51. P. 351–362. 15. Balachandran J.S., Bakker J.P., Rahangdale S. et al. Effect of mild, asymptomatic obstructive sleep apnea on daytime heart rate variability and impedance cardiography measurements // Am J Cardiol. 2012. V. 109. P. 140–145. 16. Barcelo A., Barbe F., de la P.M., et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea // Thorax. 2008. V. 63. P. 946–950. 17. Bełtowski J. Leptin and the regulation of endothelial function in physiological and pathological conditions // Clin Exp Pharmacol Physiol. 2012. V. 39. P. 168–178. 18. Bondia-Pons I., Ryan L., Martinez J.A. Oxidative stress and inflammation interactions in human obesity // J. Physiol. Biochem. 2012. V. 68. P. 701–711. 19. Botros N., Concato J., Mohsenin V. et al. Obstructive sleep apnea as a risk factor for type 2 diabetes // Am J Med 2009. V. 122. P. 1122–1127. 20. Kasai T., Bradley T.D. Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications // J Am Coll Cardiol. 2011. V. 57. P. 119–127 21. Braga B., Poyares D., Cintra F. et al. Sleep-disordered breathing and chronic atrial fibrillation // Sleep Med. 2009. V. 10. P. 212–216. 22. Broocs D., Horner R.L., Floras J.S. et al. Baroreflex control of heart rate in a canine model of obstructive sleep apnea // Am J RespirCrit Care Med. 1999. V. 159. P. 1793–1797. 23. Bryan S., Baregzay B., Spicer D. et al. Redox-inflammatory synergy in the metabolic syndrome // Can J Physiol Pharmacol. 2013. V. 91. P. 22–30. 24. Bulcun E., Ekici M., Ekici A. Disorders of glucose metabolism and insulin resistance in patients with obstructive sleep apnoea syndrome // Int J Clin Pract. 2012. V. 66. P. 91–97. 25. Calhoun D.A., Nishizaka M.K., Zaman M.A. et al.. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea // Chest. 2004. V. 125. P. 112–117. 26. Cappuccio F.P., Taggart F.M., Kandala N.B. et al. Meta-analysis of short sleep duration and obesity in children and adults // Sleep. 2008. V. 31. P. 619–626. 27. Cho K.I., Kwon J.H., Kim S.M. et al. Impact of obstructive sleep apnea on the global myocardial performance beyond obesity // Echocardiography. 2012. V. 29. P. 1071–1080. 28. Chobanian A.V., Bakris G.L., Black H.R. et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure // Hypertension. 2003. V. 42. P. 1206–1252. 29. Cizza G., Piaggi P., Lucassen E.A. Obstructive sleep apnea is a predictor of abnormal glucose metabolism in chronically sleep deprived obese adults // PLoS One. 2013. V. 8. 30. Clarenbach C.F., West S.D., Kohler M. Is obstructive sleep apnea a risk factor for diabetes? // DiscovMed. 2011. V. 12. P. 17–24. 31. Coen P.M., Goodpaster B.H. Role of intramyocelluar lipids in human health // Trends Endocrinol Metab. 2012. V. 23. P. 391–398. 32. Crummy F., Piper A.J., Naughton M.T. Obesity and the lung: 2. Obesity and sleep-disordered breathing // Thorax. 2008. V. 63. P. 738–746. 33. D’Archivio M., Annuzzi G., Varì R. et al. Predominant role of obesity/insulin resistance in oxidative stress development // Eur J Clin Invest. 2012. V. 42. P. 70–78. 34. Dandona P., Ghanim H., Chaudhuri A. et al. Macronutrient intake induces oxidative and inflammatory stress: Potential relevance to atherosclerosis and insulin resistance // Exp. Mol. Med. 2010. V. 42. P. 245–253. 35. de Jonge L., Zhao X., Mattingly M.S. et al. Poor sleep quality and sleep apnea are associated with higher resting energy expenditure in obese individuals with short sleep duration // J ClinEndocrinolMetab. 2012. V. 97. P. 2881–2889. 36. Dematteis M., Julien C., Guillermet C. et al. Intermittent hypoxia induces early functional cardiovascular remodeling in mice // Am J RespirCrit Care Med. 2008. V. 177. P. 227–235. 37. Einhorn D., Stewart D.A., Erman M.K. et al. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus // EndocrPract. 2007. V. 13. P. 355–362. 38. Eskafi M. Sleep apnoea in patients with stable congestive heart failure an intervention study with a mandibular advancement device // Swed Dent J Suppl. 2004. V.168. P. 1–56. 39. Feng J., Zhang D., Chen B. Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea // Sleep Breath. 2012. V. 16. P. 283–294. 40. Ferretti G., Bacchetti T., Masciangelo S., Bicchiega V. HDL-paraoxonase and membrane lipid peroxidation: A comparison between healthy and obese subjects // Obesity (Silver Spring). 2010. V. 18. P. 1079–1084. 41. Filgueiras-Rama D., Arias M., Iniesta A. et al. Atrial Arrhythmias in Obstructive Sleep Apnea: Underlying Mechanisms and Implications in the Clinical Setting // Pulm Med. 2013. V. 2013. P. 9. 42. Foster G.D., Sanders M.H., Millman R. et al. Sleep AHEAD Research Group. Obstructive sleep apnea among obese patients with type 2 diabetes // Diabetes Care. 2009. V. 32. P. 1017–1019. 43. Fredheim J., Rollheim J., Omland T. et al. Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: A cross-sectional study // Cardiovasc Diabetol. 2011. V. 10. P. 84. 44. Furukawa S., Fujita T., Shimabukuro M. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome // J Clin Invest. 2004. V. 114. P. 1752–1761. 45. Gami A.S., Howard D.E., Olson E.J., Somers V.K. Day-night pattern of sudden death in obstructive sleep apnea // N Engl J Med. 2005. V. 352. P. 1206–1214. 46. Gangwisch J.E., Dolores Malaspina D., Babiss L.A. et al. Short sleep duration as a risk factor for hypercholesterolemia: analyses of the National Longitudinal Study of Adolescent Health // Sleep. 2010. V. 33. P. 956–961. 47. Zhan G., Serrano F., Fenik P. et al. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea // Am J RespirCrit Care Med. 2005. V. 172. P. 921–929. 48. Halliwell, B. Free radicals and antioxidants: Updating a personal view // Nutr.Rev. 2012. V. 70. P. 257–265. 49. Higuchi M., Dusting G.J., Peshavariya H. et al. Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and Forkhead box O1 mediated upregulation of antioxidant enzymes // Stem Cells Dev. 2013. V. 22. P. 878–888. 50. Horvath T.L., Andrews Z.B., Diano S. Fuel utilization by hypothalamic neurons: roles for ROS. Trends Endocrinol Metab. 2009. V. 20. P. 78–87. 51. http://www.sasw2012.org/ 52. Iiyori N., Alonso L.C., Li J. et al. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity // Am J Respir Crit Care Med. 2007. V. 175. P. 851–857. 53. Ip M.S., Lam B., Chan L.Y. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure // Am J Respir Crit Care Med. 2000. V. 162. P. 2166–2171. 54. Ip M.S., Lam K.S., Ho C. et al. Serum leptin and vascular risk factors in obstructive sleep apnea // Chest. 2000. V. 118. P. 580–586. 55. Ip M.S., Tse H.F., Lam B. et al. Endothelial function in obstructive sleep apnea and response to treatment // Am J RespirCritCareMed. 2004. V. 169. P. 348–353. 56. Iwasaki Y. K., Shi Y., Benito B. et al. Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea // Heart Rhythm. 2012. V. 9. P. 1409–1416. 57. Keaney J.F., Jr., Larson M.G., Vasan R.S. et al. Framingham Study. Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham Study // Arterioscler.Thromb.Vasc. Biol. 2003. V. 23. P. 434–439. 58. Kezirian E.J., Kirisoglu C.E., Riley R.W. et al. Resting energy expenditure in adults with sleep disordered breathing // Arch Otolaryngol Head Neck Surg. 2008. V. 134. P. 1270–1275. 59. Kim S.H., Cho G.Y., Shin C. et al. Impact of obstructive sleep apnea on left ventricular diastolic function // Am J Cardiol. 2008. V. 101. P. 1663–1668. 60. Kohler M., Pepperell J.C., Casadei B. et al. CPAP and measures of cardiovascular risk in males with OSAS // Eur Respir J. 2008. V. 32. P. 1488–1496. 61. Kourouklis S.P., Vagiakis E., Paraskevaidis I.A. et al. Effective sleep apnoea treatment improves cardiac function in patients with chronic heart failure // Int J Cardiol. 2012. V. 168. P. 157–162. 62. Kunze D.L., Kline D., Ramirez-Navarro A. Hypertension in sleep apnea: the role of the sympathetic pathway // Cleve Clin J Med. 2007. V. 74. P. 34–36. 63. Lam J., Lam B., Yao T. et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea // Eur Respir J. 2010. V. 35. P. 138–145. 64. Lam J.C., Xu A., Tam S. et al. Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea // Sleep. 2008. V. 31. P. 1721–1727. 65. Lee H., Lee Y.J., Choi H. et al. Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion // J Biol Chem. 2009. V. 284. P. 10601–10609. 66. Li C., Ford E.S., Zhao G. et al. Prevalence of self-reported clinically diagnosed sleep apnea according to obesity status in men and women: National Health and Nutrition Examination Survey, 2005-2006 // Prev Med. 2010. V. 51. P. 18–23. 67. Lindberg E. Epidemiology of OSA // Eur Respir Mon. 2010. V. 50. P. 51–68. 68. Linz D., Schotten U., Neuberger H. R. et al. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation // Heart Rhythm. 2011. V. 8. P. 1436–1443. 69. Logan A.G., Perlikowski S.M., Mente A. et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension // J Hypertens. 2001. V. 19. P. 2271–2277. 70. Louis M., Punjabi N.M. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers // J Appl Physiol. 2009. V. 106. P. 1538–1544. 71. Lui M.M., Lam J.C., Mak H.K. et al. C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity // Chest. 2009. V. 135. P. 950–956. 72. Mahmood K., Akhter N., Eldeirawi K., et al. Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample // J. Clin. Sleep Med. 2009 V. 5. P. 215–221. 73. Makino S., Handa H., Suzukawa K. et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance // ClinEndocrinol (Oxf). 2006. V. 64. P. 12–9. 74. Marin J.M., Carrizo S.J., Vicente E. et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study // Lancet. 2005. V. 365. P. 1046­–1053. 75. Matiello M., Nadal M., Tamborero D. et al. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients // Europace. 2010. V. 12. P. 1084–1089. 76. McNicholas W.T. Obstructive sleep apnea and inflammation // ProgCardiovasc Dis. 2009. V. 51. P. 392–399. 77. Mehra R., Stone K.L., Varosy P.D. et al. Nocturnal Arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study // Arch Intern Med. 2009. V. 169. P. 1147–1155. 78. Meslier N., Gagnadoux F., Giraud P. et al. Impaired glucose-insulin metabo- lism in males with obstructive sleep apnoea syndrome // Eur Respir J. 2003. V. 22. P. 156–160. 79. Mlinar B., Marc J. New insights into adipose tissue dysfunction in insulin resistance // Clin Chem Lab Med. 2011. V. 49. P. 1925–1935. 80. Monahan K., Storfer-Isser A., Mehra R. et al. Triggering of nocturnal arrhythmias by sleep-disordered breathing events // J Am CollCardiol. 2009. V. 54. P. 1797–1804. 81. Narkiewicz K., Somers V.K. Sympathetic nerve activity in obstructive sleep apnoea // ActaPhysiol Scand. 2003. V. 177. P. 385–390. 82. Nena E., Steiropoulos P., Papanas N. et al. Sleepiness as a marker of glucose deregulation in obstructive sleep apnea // Sleep Breath. 2012. V. 16. P. 181–186. 83. Olivares-Corichi I.M., Viquez M.J., Gutierrez-Lopez L. et al. Oxidative stress present in the blood from obese patients modifies the structure and function of insulin. Horm Metab Res. 2011. V. 43. P. 748–753. 84. Oliveira W., Campos O., Bezerra Lira-Filho E. et al. Left atrial volume and function in patients with obstructive sleep apnea assessed by real-time three-dimensional echocardiography // J Am Soc Echocardiogr. 2008. V. 21. P. 1355–1361. 85. Onen S.H., Lesourd B., Ouchchane L. et al. Occult nighttime hypertension in daytime normotensive older patients with obstructive sleep apnea // J Am Med Dir Assoc. 2012. V. 13. P. 752–756. 86. Patel C., Ghanim H., Ravishankar S. et al. Prolonged reactive oxygen species generation and nuclear factor-kappaB activation after a high-fat, high-carbohydrate meal in the obese // J Clin Endocrinol Metab. 2007. V. 92. P. 4476–4479. 87. Pialoux V., Hanly P.J., Foster G.E. et al. Effects of exposure to intermittent hypoxia on oxidative stress and acute hypoxic ventilatory response in humans // Am J RespirCrit Care Med. 2009. V. 180. P. 1002–1009. 88. Pimenta E., Stowasser M., Gordon R.D. et al. Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism // Chest. 2013. V. 143. P. 978–983. 89. Penev. P.D. Update on Energy Homeostasis and Insufficient Sleep // J Clin Endocrinol Metab. 2012. V. 97. P. 1792–1801. 90. Polotsky V. Y., Li J., Punjabi N.M. et al. Intermittent Hypoxia Increases Insulin Resistance in Genetically Obese Mice // J Physiol. 2003. V. 552. P. 253–264. 91. Prabhakar N.R., Kumar G.K., Nanduri J. Intermittent hypoxia-mediated plasticity of acute O2 sensing requires altered red-ox regulation by HIF-1 and HIF-2 // AnnNYAcadSci. 2009. V. 1177. P. 162–168. 92. Pratt-Ubunama M.N., Nishizaka M.K., Boedefeld R.L. et al. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension // Chest. 2007. V. 131. P. 453–459. 93. Punjabi N.M., Caffo B.S., Goodwin J.L. et al. Sleep-disordered breathing and mortality: a prospective cohort study // PLoS Med. 2009. V 6. 94. Quan S.F., Howard B.V., Iber C. et al. The Sleep Heart Health Study: design, rationale, and methods // Sleep. 1997. V. 20. P. 1077–1085. 95. Rahangdale S., Yeh S.Y., NovackV. et al. The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apnea // J Clin Sleep Med. 2011. V. 7. P. 172–178. 96. Ramos-Mondragón R., Vega A.V., Avila G. Long-term modulation of Na+ and K+ channels by TGF-β1 in neonatal rat cardiac myocytes // Pflugers Arch. 2011. V. 461 P. 235–247. 97. Rechtschaffen A., Bergmann B.M. Sleep deprivation in the rat by the disk-over-water method // BehavBrainRes. 1995. V. 69. P. 55–63. 98. Reichmuth K. J., Austin D., Skatrud J. B. et al. (2005). Association of sleep apnea and type II diabetes: a population-based study // Am J Respir Crit Care Med. 2005. V.172. P. 1590–1595. 99. Resnick H.E., Redline S., Shahar E. et al. Sleep Heart Health Study. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study // Diabetes Care 2003. V. 26. P. 702–709. 100. Ronksley P. E., Hemmelgarn B. R., Heitman S. J. et al. Obstructive sleep apnoea is associated with diabetes in sleepy subjects // Thorax. 2009. V.64. P. 834–839. 101. Santana A., Pimentel G., Romualdo M. et al. Sleep duration in elderly obese patients correlated negatively with intake fatty // Lipids Health Dis. 2012. V. 11. P. 99. 102. Sauvet F., Leftheriotis G., Gomez-Merino D. et al. Effect of acute sleep deprivation on vascular function in healthy subjects // J Appl Physiol. 2010. V. 108. P. 68–75. 103. Serra D., Mera P., Malandrino M.I. et al. Mitochondrial fatty acid oxidation in obesity // Antioxid.Redox Signal. 2013. V. 19. P. 269–284. 104. Sies H., Stahl W., Sevanian A. Nutritional, dietary and postprandial oxidative stress // J. Nutr. 2005. V. 135. P. 969–972. 105. Simantirakis E. N., Schiza S. I., Marketou M. E. et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder // Eur Heart J. 2004. V. 25. P. 1070–1076. 106. Spiegel K., Tasali E., Penev P., Van Cauter E. Brief Communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite // Ann Intern Med. 2004. V. 141. P. 845–850. 107. Stamatakis K.A., Punjabi N.M. Effects of sleep fragmentation on glucose metabolism in normal subjects // Chest. 2010. V. 137. P. 95–101. 108. Stenlöf K., Grunstein R., Hedner J., Sjöström L. Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure // Am J Physiol. 1996. V. 271. P. 1036–1043. 109. Stevenson I.H., Roberts-Thomson K.C., Kistler P.M. et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea // Heart Rhythm. 2010. V. 7. P. 1263–1270. 110. Takase B., Akima T., Uehata A. et al. Effect of chronic stress and sleep deprivation on both flow-mediated dilation in the brachial artery and the intracellular magnesium level in humans // Clin Cardiol. 2004. V. 27. P. 223–227. 111. Tang R.B., Dong J.Z., Liu X.P. et al. Obstructive sleep apnoea risk profile and the risk of recurrence of atrial fibrillation after catheter ablation // Europace. 2009. V. 11. P. 100–105. 112. Taranto Montemurro L., Floras J.S., Millar P.J. et al. Inverse relationship of subjective daytime sleepiness to sympathetic activity in patients with heart failure and obstructive sleep apnea // Chest. 2012. V. 142. P. 1222–1228. 113. Thomopoulos C., Michalopoulou H., KasiakogiasA. Et al. Resistant hypertension and obstructive sleep apnea: the sparring partners // Int J Hypertens. 2011. V. 10. 114. Tsioufis C., Thomopoulos C., Dimitriadis K. et al. Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study // Am J Kidney Dis. 2008. V. 52. P. 285–293. 115. Ucok K., Aycicek A., Sezer M. et al. Resting metabolic rate and anthropometric measurements in male sleep apnea patients // InternMed. V. 50. P. 833–838. 116. Usui Y., Takata Y., Inoue Y. et al. Coexistence of obstructive sleep apnoea and metabolic syndrome is independently associated with left ventricular hypertrophy and diastolic dysfunction // SleepBreath. 2012. V. 16. P. 677–684. 117. Usui Y., Takata Y., Inoue Y. Severe obstructive sleep apnea impairs left ventricular diastolic function in non-obese men // Sleep Med. 2013. V. 14. P. 155–159. 118. Varol E., Akcay S., Ozaydin M. et al. Influence of obstructive sleep apnea on left ventricular mass and global function: sleep apnea and myocardial performance index // HeartVessels. 2010. V. 25. P. 400–404. 119. Vgontzas A.N., Papanicolaou D.A., Bixler E.O. et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity // J Clin Endocrinol Metab. 1997. V. 82. P. 1313–1316. 120. Wang S., Kaufman R.J. The impact of the unfolded protein response on human disease // J Cell Biol. 2012. V. 197. P. 857–867. 121. Weinstock T.G., Wang X., Rueschman M. et al. A Controlled Trial of CPAP Therapy on Metabolic Control in Individuals with Impaired Glucose Tolerance and Sleep Apnea // Sleep. 2012. V. 35. P. 617–625. 122. World Health Organization. Obesity and overweight. FactSheetNo 311 // http://www.who.int/mediacentre/factsheets/fs311/en/index.html. 123. Xu W., Chi L., Row B.W., et al. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cellapoptosis in a mouse model of sleep apnea // Neuroscience. 2004. V. 126. P. 313–323. 124. Yamauchi M., Kimura H. Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications // Antioxid Redox Signal. 2008. V. 10. P. 755–768. 125. Yamauchi M., Tamaki S., Tomoda K. et al. Evidence for activation of nuclear factor kappaB in obstructive sleep apnea // Sleep Breath. 2006. V. 10. P. 189–193. 126. Yang S.Q., Han L.L., Dong X.L. et al. Mal-effects of obstructive sleep apnea on the heart // Sleep Breath. 2012. V. 16. P. 717–722.    [ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]